Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally.
52W Range
10thpctl
Volume
0.44×avg
Market Cap
276.72MUSD
P/E Ratio
-7.9TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Lineage Cell Therapeutics, Inc.
LCTXNew York Stock Exchange Arca·USD·Closed
Lineage Cell Therapeutics, Inc.
LCTXNew York Stock Exchange Arca·USD·Closed
$1.11
−4.31%
$1.11
−$0.05 (4.31%)
52W Range
10thpctl
Volume
0.44×avg
Mkt Cap
276.72MUSD
P/E
-7.9TTM
Div Yield
–ann
LCTX: Lineage Cell Therapeutics, Inc. Stock Analysis | finqOS
